Improving Business Performance through Innovation Strategy and Total Quality Management practice: Survey on the Pharmaceutical Industry In Indonesia by Syoemantri, Yuli Fitriyani et al.
Hasanuddin Economics and Business Review 04:3 (2021) 1–12
Improving Business Performance through Innovation Strategy and Total Quality
Management Practice: Survey on the Pharmaceutical Industry in Indonesia
Yuli Fitriyania,∗, Yudi Aziza, Irvan Rivania, Umi Kaltuma, John Sihotanga
aMaster of Management Program Faculty of Economics and Business, Padjajaran University, Indonesia
Abstract
The main purpose of this research is to analyze the relationship between innovation strategy and Total Quality Management
(TQM) in improving business performance. The object of study of this research is the pharmaceutical Industries in Indonesia.
This research reveals the proper innovation strategy execution and effective implementation of TQM in business performance
improvement. In this context, data collected from 168 managers at 42 firms operating in the pharmaceutical industry in Indonesia
were analyzed. The partial least squares structural equation modeling (PLS-SEM) method is used to test the hypotheses both of
reflective and formative construct with second-order/higher-order construct in our model of study which is rarely found in the
previous study. The findings support the hypothesis that there is a positive and significant effect of innovation strategy and TQM on
improving the business performance of the company. The result of this research will have strategic implications for the company
and expect to be used as feedback related to the execution of their innovation strategies and TQM implementation promptly to
improve their business performance.
Keywords: innovation strategy, total quality management, business performance, strategic management happiness at work, work
motivation, employee performance
1. INTRODUCTION
Today, the pharmaceutical industry in Indonesia is one of
the priority sectors because it is considered to provide a sig-
nificant contribution to the growth of the Indonesian economy.
The pharmaceutical industry market grew 7.5% until the fourth
quarter of 2016, higher than the same period in the previous
year which was 4.9% (Kalbe Farma, 2018).
One of the driving factors for pharmaceutical industry growth
is the widespread participation of the National Health Insurance
(Jaminan Kesehatan Nasional/JKN) or BPJS (Badan Penyeleng-
gara Jaminan Sosial kesehatan). JKN is health protection pro-
gram provided by the Indonesian Government that covered ba-
sic health needs given to everyone who has paid contributions
or fees paid by the government. This program aims to provide
health insurance for all Indonesians and expatriates working in
Indonesia for more than 6 months.
JKN program will continue to be the main driver for the
development of the healthcare and pharmaceutical industries,
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Figure 1: Pharmaceutical Industry Market in Indonesia, 2012-2016
Source: IMS Health, 2017
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Figure 2: Growth of JKN Program Participants, 2014-2019
Source: BPJS, July 2018
where the health industries continue to record growth in the
number of BPJS Kesehatan participants which reached around
199 million in July 2018. This is in line with the initial plan
of the JKN program which targeted 100% coverage in 2019 for
the entire Indonesian population of 250 million.
Even though pharmaceutical industry growth is increasing,
however, its growth in 2016 was lower compared to the com-
pound annual growth rate (CAGR) growth in 2012-2016 worth
8.9%. This is caused by the JKN implementation. In terms
of quantity, medicine consumption has indeed increased, but
sales have decreased, since most medicine used in JKN pro-
gram was generic drugs which selling price has been set by the
government through the Government Agency for Procurement
of Goods and Services Policy, meanwhile the price is not ne-
gotiable. Some pharmaceutical industries in Indonesia face a
slowdown in business growth. For example, PT Kalbe Farma
Tbk, they experienced a slowdown in business growth from the
2014-2016 period reaching 14.7%. However, in 2016-2017 the
company’s sales growth was only around 4.5% (Kalbe Farma,
2018).
Most of the generic drugs sold under the JKN program are
cheaper so that they cannot drive sales much higher for the com-
pany. Other causes are 90% of raw materials for medicine pro-
duction originating from imports and high cost of distribution.
Pharmaceutical companies must distribute their medicines to
remote areas far from factories with the same selling price be-
cause they are participating in the JKN program. New chal-
lenges for the pharmaceutical industry in Indonesia in the JKN
system implementation era are able to produce cheap medicines
but still, the quality should be guaranteed. To obtain marketing
authorization, medicinal products should meet the standards of
quality, efficacy, and safety that have been determined in ac-
cordance with the regulation of Good Manufacturing Practices
(GMP).
This phenomenon raises questions about key success factors
related to the effectiveness of corporate strategies that must be
implemented in order to survive and grow sustainably with the
change in the business landscape of the pharmaceutical industry
which is currently undergoing changes to the insurance market,
namely producing generic drugs at low prices (low cost and
low margin medicines). To overcome these challenges, while
ensuring sustainable growth of the pharmaceutical industry in
Indonesia, an innovation strategy in terms of research and de-
velopment and industrial raw materials are needed as an op-
portunity for improving business in the pharmaceutical indus-
tries. Innovation can have a significant impact on the perfor-
mance of a company’s business through better market share,
thus increasing the competitiveness of the company and ulti-
mately will have an impact on improving its business perfor-
mance. In today’s competitive world, it is concluded that using
old methods will not be efficient anymore. New technology and
product innovation are some new techniques that are currently
considered to be implemented globally in order to survive in the
competition (Tohidi and Jabbari, 2012).
Innovation has played a significant role in creating unique
products and services, in order to get value-added for the com-
pany and then determine constraints to entry for new rivals (An-
tunes et al., 2017). However, the company is impossible to get
avail from the innovation advantages if there is no organiza-
tional structure that is deemed qualified to follow these strate-
gies. Based on these reasons, innovation has triggered the in-
terest of many researchers to identify the driving factors, and
one of the problems that have been considered is whether the
practice of TQM can emerge as one of the supporting factors of
the innovation strategy. The intense global competition has had
an impact on the development of TQM concept (Ahmad et al.,
2012).
In the literature, it can be found opposite ideas, and that
is why there is no consensus about whether innovation creates
conditions for the application of TQM or TQM actually helps
create an environment and culture to support innovation (An-
tunes et al., 2017). One of the goals of this research is to con-
tribute in an enriching way to the study of these variables, based
on Indonesian pharmaceutical companies. Thus, it is intended
in this research to analyze the relationship between innovation
strategy and TQM in improving business performance. Fur-
thermore, we use both of reflective and formative constructs
with second-order/higher-order construct in our model of study
which is rarely found in the previous study.
The result of this research will have strategic implications
for the company and expect to be used as feedback related to the
execution of their innovation strategies and TQM implementa-
tion promptly to improve their business performance.
2. LITERATURE REVIEW
Several previous studies regarding the role of innovation
strategy on the company’s business performance showed a pos-
itive relationship between the two from various dimensions,
for example, Al-Battaineh (2018) revealed that product inno-
vation, process innovation, and innovation management had a
positive influence on improving the company’s business perfor-
mance. Other researchers also argued that process innovation
and product innovation have a positive impact on a company’s
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Table 1: Sales Growth of Pharmaceutical Industries in Indonesia




1 PT Darya-Varia Laboratoria Tbk 8.56% 11.12%
2 PT Kimia Farma (Persero) Tbk 5.44% 19.6%
3 PT Kalbe Farma Tbk 4.17% 8.3%
4 PT Industri Jamu dan Farmasi
Sido Muncul Tbk
0.47% 55.2%
5 PT Tempo Scan Pacifik Tbk 4.68% 11.7%
6 PT Indofarma (Persero) Tbk -2.59% 3.3%
7 PT Millennium Pharmacon In-
ternational Tbk
7.14% 15.4%
8 PT Merck Sharp Dohme Tbk -8.97% 38.9%
Source: Company’s Financial Statement in Year 2016-2017
performance (Murat Ar and Baki, 2011). However, there is a
research gap where other researchers revealed different conclu-
sions. From a different perspective, Riyadi and Sumardi (2017)
revealed that process innovation has a greater influence in im-
proving the competitiveness of a company’s business compared
to other innovation strategies, namely product innovation and
administrative innovation.
An empirical study conducted by Zehir et al. (2012) con-
firmed the positive relationship between TQM and innovation
performance. Whereas Martı́nez-Costa et al. (2008) revealed
different results, that TQM culture has a direct influence on im-
proving the process and product design capabilities but does not
affect product innovation. Other researchers’ opinions support
the negative relationship between TQM and innovation perfor-
mance claimed that TQM can make organizations think nar-
rowly and inhibit creativity because of the standardization prac-
tice (Zehir et al., 2012).
Meanwhile, Juran (2001) stated that one of TQM dimen-
sion, namely customer orientation has a significant positive re-
lationship to innovation because customer focus can encourage
companies to always meet the customer’s needs and desires so
that the company can survive in a competitive business environ-
ment. To clarify the issue in previous studies, the author is in-
terested in conducting further investigation on the relationship
between innovation strategy and TQM associated with business
performance. One of the goals of this research is to contribute
in an enriching way for the study of these variables to capture
the current situation of the innovation strategy execution, TQM
implementation, and business performance of the pharmaceuti-
cal industry in Indonesia today. This research is expected to be
used as feedback for companies related to the execution of their
innovation strategies and TQM implementation promptly to im-
prove their competitive advantage, thus improving the com-
pany’s business performance and creating sustainable growth.
2.1. Innovation Strategy and TQM
Innovation plays a very important role in providing unique
products and services, creating value-added for the company,
and defining entry barriers for new entrants. For this reason, in-
novation has triggered the interest of many researchers to iden-
tify the drivers, and one of the issues that have been considered
is whether the practice of TQM can emerge as one of the fac-
tors that influence the company’s innovation strategy. In the
current business context with global competition and high in-
tensity of competitiveness, evaluation of business performance
has become a very important element in the development of
the organizational strategy. Performance evaluation can be de-
fined as a process for measuring the efficiency and effectiveness
of a production system. Thus, innovation strategy can have
a positive effect on business performance. However, compa-
nies cannot obtain benefit from innovation if there is no orga-
nizational structure established to follow the strategy (Antunes
et al., 2017).
Many researchers have revealed the results of empirical stud-
ies that the application of quality management has a positive
relationship with innovation. The empirical study showed that
this practice can train experts and specialists in research and
development, create opportunities to apply these principles and
quality management techniques in their innovation activities,
thus they can find new target markets and potential customers,
increase knowledge, and continue to improve their systems and
work processes. Therefore, quality management practice to-
ward innovation might help companies to improve their perfor-
mance to satisfy customers, to minimize activities that do not
create value-added, and reduce time and costs in developing
new products (Kim et al., 2012).
Other studies have found that one of the key dimensions
of TQM, which is customer orientation, has a significant im-
pact to innovation. Customer orientation encourages organiza-
tions to fulfill customer needs and expectations consistently, so
that the company can survive in a competitive environment in
today’s global market. In addition, continuous improvements
made by the company is also important for the success of in-
novation through encouraging changes and creative thinking in
generating new ideas. Zehir et al. (2012) found that all dimen-
sions of TQM significantly give positive impact to innovation.
An empirical study conducted by Zehir et al. (2012) confirmed
the positive relationship between TQM and innovation perfor-
mance. Whereas Miranda Silva et al. (2014) revealed different
results, that the TQM culture has a direct influence on improv-
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ing the process and product design capabilities but does not af-
fect product innovation. Other researchers’ opinions support
the negative relationship between TQM and innovation perfor-
mance claimed that TQM can make organizations think nar-
rowly and inhibit creativity because of the standardization prac-
tice (Martı́nez-Costa et al., 2008).
2.2. Innovation Strategy and Business Performance
Many studies revealed that innovation has played an impor-
tant role in social and economic development and increases the
competitiveness of companies. Innovation, like the terms used
in business, are intended to describe new products, services,
methods, and organizational approaches that enhance competi-
tiveness of the company. The results of the Global Innovation
survey conducted by the Boston Consulting Group (BCG) in
2014 revealed that innovation is the top 3 priority for three quar-
ters of companies in the world. As many as 75% of respondents
stated that investment in terms of innovation is primarily aimed
at long-term benefits and the current competitive advantage that
the company cares about (Wheelen et al., 2018).
Innovation strategy is a plan to increase market share or
company profits through product and service innovation. When
looking at innovation strategy through the eyes of the work that
must be done, it appears that the strategy must be effective and
correctly inform the executors of work, jobs, and which seg-
ments are targeted to achieve the highest growth, as well as
unmet targets to give our customers better products. The in-
novation strategy, in the simplest terms, is to choose the most
appropriate strategy among possible alternative options and de-
velop the most appropriate type of action that is possible to be
implemented at present (Al-Battaineh, 2018). The theory of
innovation strategy stated that companies that have good busi-
ness performance are constantly reviewing their products and
services (their offerings), modifying their existing ones and de-
veloping something new in order to meet customers need better
that previously unmet (David and David, 2017).
Previous studies regarding the role of innovation strategy
on the company’s business performance showed a positive re-
lationship between them from various dimensions, for example
Al-Battaineh (2018) revealed that product innovation, process
innovation, and innovation management had a positive influ-
ence in improving the company’s business performance. Other
researchers, Beyene et al. (2016) explained that innovation strat-
egy are positively related to product innovation performance.
Whereas Riyadi and Sumardi (2017) revealed different perspec-
tives that process innovation has a greater influence in increas-
ing the competitiveness of a company’s business compared to
other innovation strategy, namely product innovation and ad-
ministrative innovation. In addition, Antunes et al. (2017) ar-
gued that companies that adopt strategies of process innovation
get improvements in their performance, both operationally and
financially, while product innovation only provides improve-
ments in the financial performance of organizations.
2.3. TQM and Business Performance
TQM is an integrated business management strategy aimed
at instilling quality awareness in all company processes (Swink
et al., 2014). The International Standards Organization (ISO)
defines TQM as a management approach for an organization,
which is quality-centered, based on the participation of all its
members and aims at long-term success through customer sat-
isfaction and benefits for all members of the organization and
also for society (ISO 8402: 1994). Today, TQM can be a major
factor in achieving competitive advantage for companies. This
is because the TQM concept allows organizations to run the
company efficiently, improve employee productivity, materials
and also improve product quality (Martı́nez-Costa et al., 2008).
In the past few decades, as has been demonstrated through
many publications, TQM has a significant role in improving
business performance because it affects the growth and perfor-
mance of the company so that the company continues to achieve
continuous improvement as an important integral part of its or-
ganizational strategy (Jonah et al., 2018). The relationship be-
tween TQM and performance has been investigated by many
researchers on various types of performance, including finan-
cial performance, operational performance and quality perfor-
mance.
Although the effects of TQM on various types of perfor-
mance are inconsistent, quality performance generally shows a
strong and positive relationship (Zehir et al., 2012). According
to Deming, quality is the main determinant of the company’s
success in a competitive business environment. Quality man-
agement is an activity that is increasingly important for all types
of companies and is associated with corporate strategies to gain
competitive advantage (López-Mielgo et al., 2009). Other re-
searchers mentioned that some dimensions of TQM, especially
those related to leadership and education, have a stronger cor-
relation with business performance (Cetindere et al., 2014).
Thus, in this research, it is considered relevant the study of
this issue since the study carried out previously showed contra-
dictory results regarding relationship between innovation and
TQM in business performance. The result of the study is ex-
pected to be used as feedback for companies related to the ex-
ecution of their innovation strategies and TQM implementation
promptly to improve their business performance. For academic
interests, this research is expected to be used as empirical evi-
dence regarding the influence of corporate innovation strategies
and the implementation of TQM on business performance.
2.4. Proposed Framework and Research Hypotheses
The proposed framework in this study will focus on the
business performance of the pharmaceutical industry in Indone-
sia which is related to innovation strategy and implementation
of TQM based on literature and previous research are two im-
portant factors that plays an important role in supporting the
company’s performance where the two variables are correlated
to improve the company’s business performance.
In this research, the authors use the dimensions of product
innovation, process innovation, administrative innovation and
innovation management to measure innovation strategy. Those
dimensions are based on previous research that product innova-
tion and administrative innovation have a less significant influ-
ence on business performance so that it needs further investiga-
tion. Meanwhile, the constructs of TQM in the pharmaceutical
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industry in this study are leadership management, continuous
improvement, management commitment, supplier quality, cus-
tomer orientation, employee involvement, and quality manage-
ment systems. The determination of the seven dimensions is
based on previous research, including Zehir et al. (2012), Ku-
mar and Prasad (2017), also the unit of analysis in this research
is the pharmaceutical industry which has strict rules related to
the production process and the products produced must meet
GMP regulations which tend to still have weaknesses in those
seven dimensions.
Business performance will be measured based on the per-
formance of business functions. Business performance is de-
fined as performance that is part of the company’s business
functions that support the company’s overall performance based
on four perspectives namely financial, customer, internal busi-
ness processes and learning and growth. Therefore, the perfor-
mance of business functions must be aligned with the perfor-
mance of the company so that the company can meet predeter-
mined targets. One of the most popular approaches for measur-
ing business performance is the balanced scorecard (BSC). BSC
can capture both financial element and non-financial strategies
of the company and discuss causal relationships that can im-
prove business results (Muiruri and Kilika, 2015). Robert Ka-
plan and David Norton developed this approach for the first
time. To establish a company’s future vision and provide a com-
petitive advantage, financial data must be defined in intangible
indicators (Lyibildire and Karasioglu, 2018).
Despite the previous studies showed the positive relation-
ship between innovation strategy and TQM implementation, in-
cluding Zehir et al. (2012). However, some researchers revealed
different results, that TQM might be an inhibitor for innova-
tion (Dinh et al., 2006). Therefore, it was considered relevant
to investigate the relationship between innovation strategy and
implementation of TQM. The study model is given in Figure 3.
Based on the model, three different hypotheses were formed:
Q1 – Is there any relationship between innovation strategy
and TQM implementation?
H01: There is no significant relationship between innovation
strategy and TQM implementation.
H1: Innovation strategy and TQM implementation are in-
terconnected with each other.
As described previously, several studies have shown inno-
vation strategy gave a positive relationship to business perfor-
mance (Al-Battaineh (2018) and Beyene et al. (2016). How-
ever, Riyadi and Sumardi (2017) revealed different perspectives
that process innovation has a greater influence in increasing the
competitiveness of a company’s business compared to another
innovation strategy.
Thus, it is considered relevant to the analysis of this rela-
tionship based on the following hypotheses:
Q2: What impact the adoption of innovation strategy might
reflect on business performance?
H02: The adoption of an Innovation strategy does not have
a positive influence on business performance
H2: The adoption of innovation strategy encourages the im-
provement of business performance.
Figure 3: Model of research
Several studies were designed to investigate the relation-
ship between TQM and business performance. Although the
effects of TQM on various types of performance are inconsis-
tent, quality performance generally shows a strong and positive
relationship (Zehir et al., 2012). Other researchers revealed that
TQM is positively associated with business performance such
as financial and profitability (Nair and Choudhary, 2016). How-
ever, Cetindere et al. (2014) revealed a different perspective that
dimensions of TQM related to leadership and education, have
a stronger correlation with business performance compared to
other dimensions. It is, therefore, necessary to analyze the rela-
tionship between TQM and business performance to clarify the
issue, research hypotheses are defined as follows:
Q3 – What impact TQM implementation might reflect on
business performance?
H03: The implementation of TQM does not reveal an im-
provement in their business performance
H3: The implementation of TQM reveals an improvement
in their business performance.
3. METHODS
This research is conducted at pharmaceutical companies in
Indonesia and focused on the strategic management field that
reviews the strategy of innovation and TQM implementation to
improve the company’s business performance.
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This research used a questionnaire survey method conducted
during September-October 2019, through a descriptive and ver-
ification approach. The descriptive approach aims to obtain a
description of the nature and characteristics of variables being
studied related to the phenomenon happening in the object of
study, to identify and analyze the relationships between vari-
ables. The verification research aims to test the hypothesis car-
ried out through data collection (survey questionnaire). This
study will be tested whether the innovation strategy and TQM
have an influence on improving the business performance of
pharmaceutical companies in Indonesia. Verification analysis
was carried out using Partial Least Square Structural Equation
Modeling (PLS-SEM). PLS is a method that can be used to
analyze both reflective and formative constructs (Abdillah and
Jogiyanto, 2015). In this study, business performance based on
the balanced scorecard is a formative construct, while the inno-
vation strategy and TQM are reflective constructs.
3.1. Sampling Method
The method of distributing questionnaires, using purposive
sampling technique and quota sampling method, where non-
random sampling previously determined by researchers with
the following considerations: information needs for research
and characteristics in the population. Sample criteria in this
research are pharmaceutical companies in Indonesia that man-
ufactured generic drugs and participated in providing drugs for
JKN program. Quota sampling is set by determining sample
represents at least fifty percent of the market share of the phar-
maceutical industry that produced generic drugs and partici-
pated in providing drugs for the JKN program, the data obtained
is expected to be relevant and represented the current situation
of the pharmaceutical industry in Indonesia.
According to data from the Food and Drug Supervisory
Agency and the Indonesian Ministry of Health, as of the second
quarter of 2019 there were around 94 pharmaceutical compa-
nies producing generic drugs and participating as providers of
drugs for the National Health Insurance Program (BPJS Kese-
hatan). Of these, 35 companies have market shares above 0.1%,
while the rest have market shares between 0.00% - 0.09%.
3.2. Data Collection
Hair et al. (2017) stated that the minimum use of samples in
the Partial Least Square (PLS) analysis is based on (a) ten times
the size of the most formative indicators used to measure one
latent variable, or (b) ten times the highest number of structural
paths directed at certain latent variables in the structural model.
The structural path indicator in this study is 3, thus the mini-
mum PLS sample in this study is at least 30 companies.
The questionnaire was distributed using the online method.
This method provided the benefit of being able to collect a lot
of data in a short time.
Since this research measures the business performance based
on business function, it is determined that respondents for each
company are employees at the level of middle management to
top management who are responsible for making decisions re-
lated to research variables, starting from assistant manager, sec-
tion chief, manager, head of department, senior manager, gen-
eral manager, and Director. Each company is represented by
four respondents so that it is expected to be able to represent
four perspectives of company performance based on a balanced
scorecard, namely financial, customers, internal business pro-
cesses, and learning growth.
3.3. Measurement
This research uses a 5 point rating scale, referring to the
Likert Scale in general. The answers to each instrument with
this Likert scale have gradations from very positive to very
negative. The data obtained is then processed by the PLS-
SEM (Partial Least Square-Structural Equation Modeling) us-
ing SmartPLS 3.0 software. First, researchers develop a de-
scriptive analysis of the items, followed by an analysis of causal
relationships using path analysis to explain direct and indirect
influence between variables and to investigate the influence thro-
ugh a path diagram of the causal relationship between indepen-
dent variables on the dependent variable. In this study, the de-
scriptive analysis of each variable is divided into 5 categories
of measurement results with the percentage of respondents’ an-
swers as listed in the Table 2.
Following that, hypothesis test with the bootstrapping met-
hod to produce the statistical test used (t test). Significance
value used is α = 0.05. Lastly, it is proceeded to a correlation
analysis between the constructs on the level of dimensions and
indicators of each variable studied in this research.
A strong correlation between constructs and the question
items and a weak relationship with other variables is a way to
test the construct validity. Construct validity consists of con-
vergent validity and discriminant validity. Convergent validity
is achieved if construct indicators have high correlations and
have sufficient loading scores. Not only in loading scores, but
validity is also shown by the convergence of all construct indi-
cators. According to Vincenzo et al. (2010) the rule of thumb
used for convergent validity is outer loading > 0.7, 0.5 and Av-
erage Variance Extracted (AVE) > 0.5.
Meanwhile, according to Hair et al. (2017), the loading value
≥ 0.5 is considered significant. Reliability tests are in line with
construct validity used to measure the consistency of respon-
dents in answering question items in questionnaires or research
instruments (quantitative). We used composite reliability (CR)
to measure reliability since it measures the true reliability value
of a construct (Abdillah and Jogiyanto, 2015) According to Hair
et al. (2017). Rule of thumb alpha value of Composite reliabil-
ity must be greater than 0.7 although the value of 0.6 is still
acceptable. For all the measures, both indices are higher than
the evaluation criteria of 0.5 for the loading value and AVE and
0.7 for composite reliability (see Table 3).
As stated before, the business performance variable (Y) is
a formative construct. Parameters to assess its convergent va-
lidity using an outer weight of each indicator compared to one
another to determine which indicator gives the biggest contri-
bution in one construct and VIF (variance inflation factor) to
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Table 2: Interval value categories
Range of Scores Innovation Strat-
egy (X1)
TQM (X2) Business Perfor-
mance (Y)
1.00 - 1.79 Very Ineffective Very bad Very Low
1.80 - 2.59 Ineffective Bad Low
2.60 - 3.39 Quite effective Fair Fair
3.40 - 4.19 Effective Good High
4.20 - 5.00 Very effective Very good Superior/ outstand-
ing
Table 3: PLS Test Parameter
Model Test PLS-SEM Output
Outer model (structural test)
Convergent Validity (loading factor/ AVE/ outer weight,
VIF)
Discriminant Validity (Cross loading factor)
Composite reliability
Inner model (measurement test)
R Square (R2)
T statistic Test (estimated path coefficient)
Source: Abdillah & Jogiyanto, 2015
quantify the severity of multicollinearity between formative in-
dicators. High correlation is not expected between formative
indicators since the indicator’s informative models are not in-
terchangeable. VIF < 5 indicates no critical levels of collinear-
ity (Hair et al., 2017). Both outer weight and VIF value meets
the specification (see Table ??)
Discriminant validity is achieved not only when the loading
score meets the criteria but also indicated by correlation dis-
crimination (cross-loading value), it means that each indicator
loading should be greater than all of its cross-loadings. It is
found that the value of the loading factor indicator for all in-
tended indicators has the highest value compared to the value
of the loading factor for the other dimensions. For example,
the loading factor value of indicator Y.35 (for learning Growth
dimension) has the highest loading factor value, which is 0.738
compared to the value of the other dimension loading factor.
Thus, the value of the correlation indicator in a variable is better
than the indicator for other variables, meaning that our research
model meets discriminant validity.
The relationship between innovation strategy variables (X1)
and TQM (X2) to the construct is a manifest indicator (reflec-
tive), whereas the relationship of business performance indica-
tors (Y) to the construct is a formative indicator and those were
second-order construct / higher-order construct (HOC) model).
One of the advantages of PLS compared to other analytical
methods is being able to measure formative and reflective con-
structs in one research model. Previous researchers used sev-
eral approaches to specify and estimate the reflective-formative
higher-order construct (HOC) model in PLS-SEM, namely the
repeated indicators approach and the two-stage approach (ex-
tended repeated indicator approach). The results showed that
the indicator repetition approach produced a smaller bias in es-
timating the higher-order construct measurement model, namely
the relationship between the lower and higher-order compo-
nents. In contrast, the two-stage approach shows better re-
covery parameters in path analysis 1) exogenous constructs to
HOC, and 2) from HOC to endogenous constructs in the path
model (Sarstedt et al., 2019).
To validate the overall model, the Goodness of Fit (GoF) pa-
rameter is used. GoF index is a single measurement used to val-
idate the performance combination of the measurement model
(outer model) and structural model (inner model). According
to Abdillah and Jogiyanto (2015), the value of the GoF Index
is derived from the roots of the average communalities index
multiplied by the average of the R2 model. GoF values have a
range between 0-1, with a classification of small GoF values at
0.1, moderate GoF at 0.25, and a substantial GoF value at 0.36.
4. RESULTS AND DISCUSSION
Based on questionnaire results received back from man-
agers working in the pharmaceutical industry producing generic
drugs and participating in providing drugs for the JKN pro-
gram during September-October 2019 period, there were 42
pharmaceutical companies with a total of 168 respondents who
filled the questionnaire and represented a total market share of
generic drugs manufacturers of 77.15% which means have met
the specified quota sampling requirements, which represent a
minimum of 50% of the market share of the generic drug in-
dustry and a minimum of 30 companies.
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Table 4: Descriptive analysis result
No. Variable Dimension Average Respon-
dent Perception
Category
Product Innovation (IPd) 3.56 Effective
1 Innovation
Strategy
Process Innovation (IPr) 4.02 Effective
Administrative innovation (IA) 3.76 Effective
Manajemen Inovasi (X1.4) 3.76 Effective
Average of Innovation Strategy 3.78 Effective
Leadership management (MK) 4.04 Good
TQM Continuous improvement (PB) 3.87 Good
2 Management commitment (KM) 3.81 Good
Supplier quality (KP) 3.8 Good
Customer orientation (OP) 3.88 Good
Employee involvement (KK) 3.89 Good
Management quality system (SMK) 4.1 Good
Average of TQM 3.95 Good




Internal Business Process (KI) 3.98 High
Learning and Growth (KL) 3.73 High
Average of Business Performance 3.7 High
Source: Research calculations
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The result (see Table 4 shows that respondents’ perceptions
about innovation strategy viewed based on the dimensions of
product innovation, process innovation, administrative innova-
tion, and innovation management are in the effective category
with an average value of 3.78. Respondents’ perceptions re-
lated to the implementation of TQM which were assessed based
on the dimensions of Leadership Management, Management
Commitment, Supplier Quality, Customer Orientation, Contin-
uous Improvement, Employee Involvement, and Quality Man-
agement System are well implemented (good category) with an
average value of 3.95, whereas respondents’ perceptions about
business performance viewed based on the dimensions of fi-
nancial, customer, internal business process and learning and
growth performance are in the high category with average value
3.70. Table 5 is the result of the path coefficient analysis with
the Higher Order Construct - standard repeated indicator ap-
proach.
The Table 5 is the result of the path coefficient analysis with
the Higher-Order Construct - standard repeated indicator ap-
proach. R square is the best indicator of the explanatoriness de-
gree of the regression model. Here, a 99.6% linear correlation
was found between R square the dependent variable (business
performance), and the independent variable (innovation strat-
egy and TQM). This means that 99.6% of the business per-
formance variable is explained by the innovation strategy and
TQM variable.
Table 6 presents the correlation matrix of all variables. It
shows a high degree of significant correlation between innova-
tion strategy and TQM, innovation strategy and business per-
formance, and TQM and business performance (correlation is
significant at 0.05 level, p values ¡ 0.05, T statistics ¿ 1.96). The
direction of the positive relationship is indicated by the positive
original sample value. The significant correlation between in-
novation strategy, TQM and business performance confirms our
study’s hypotheses.
The present study sought to analyze the relationship be-
tween innovation strategy and TQM in improving the business
performance of the Pharmaceutical Industry in Indonesia. Sur-
vey results show that the execution of innovation strategy is
in the effective category with an average value of 3.78, TQM
is well implemented (good category) with an average value of
3.95, whereas business is in the high category with an average
value of 3.70. This indicates that the pharmaceutical industry in
Indonesia has good awareness in responding to business land-
scape changes since JKN implementation in 2014 which is to
manufacture drugs with low cost and low margin.
In terms of our hypotheses (Table 6) findings for H1 (In-
novation strategy on TQM) confirm that implementation of the
TQM system in a company interconnected with the Innovation
strategy. This supports the findings of prior researches (Hung
et al., 2011) that TQM implementation significantly gives a pos-
itive impact on innovation strategy in a company. One of the
TQM dimensions, continuous improvement will provide an en-
vironment for the company to make innovation in order to meet
customer needs and expectations.
The next results for hypothesis H2 (Innovation strategy Busi-
ness Performance) show that there is a positive correlation be-
tween those variables in all dimensions. This finding aligns
with previous studies regarding the role of innovation strategy
on the company’s business performance in various dimensions
(Al-Battaineh (2018) and Antunes et al. (2017).
The further result shows that innovation management and
product innovation give a bigger impact statistically (in terms of
loading factor and R square) to innovation strategy compared to
process innovation and administrative innovation. This proves
the important role of innovation management in pharmaceuti-
cal companies in formulating corporate innovation strategies is
in line with the company’s vision and right on target. Some
pharmaceutical companies in Indonesia have specialized de-
partments that manage corporate innovation programs, called
corporate planning strategy. The department’s responsibilities
include analyzing business trends (e.g changes in the company’s
strategic focus, merger acquisition opportunities), analyzing
opportunities and threats both internal and external to develop
new ideas, new products/services/processes, those are then used
as work programs in the RD Department.
The results also support the findings of previous researchers
(Simani and Kenyatta (2017), Simani and Kenyatta (2017), and
Hassan et al. (2012)) who revealed clear evidence for the con-
cept that companies that implemented TQM reveal an improve-
ment in their business performance (in terms of financial and
non-financial aspect). Leadership management (loading fac-
tor= 0.914, R Square of 0.836) shows the biggest contribution
to TQM implementation statistically. This proves that the role
of the leader in the implementation of TQM is very important,
one of the examples is in terms of communicating a quality cul-
ture to all employees in the company.
Several previous studies have been conducted and look into
these dimensions, however, we believe the findings of this re-
search formulate a number of important additions to the ex-
isting literature by fill a gap concerning some disagreements
identified in previous investigations both of the ambiguity of
the findings also concerning the different interpretations of the
concepts studied. This research had the particularity to analyze
the variable of innovation strategy in various dimensions, it was
considered product innovation, process innovation, administra-
tive innovation, and management innovation. Regarding the
TQM, this research analyzed this variable through leadership
management, continuous improvement, management commit-
ment, supplier quality, customer orientation, employee involve-
ment, and quality management systems. For business perfor-
mance, this research analyzed this dimension based on the bal-
anced scorecard concept, namely financial, customer, internal
business process, and learning growth perspective. This re-
search also provides a unique contribution to the analysis of
the inter-dependencies between innovation strategy and TQM
in improving business performance in Indonesian Pharmaceuti-
cal companies. Thus it will have strategic implications for the
company and expect to be used as feedback related to the exe-
cution of their innovation strategies and TQM implementation
promptly to improve their business performance.
Fitriyani et al. / Hasanuddin Economics and Business Review 04:3 (2021) 1–12 10







1 Product Innovation (IPd) 0.906 0.664 0.836 0.821
2 Process Innovation (Ipr) 0.895 0.563 0.901 0.802
3 Administration innovation (IA) 0.805 0.819 0.887 0.648
4 Innovation Management (MI) 0.918 0.739 0.919 0.843
TQM (X2)
1 Management Commitment (KM) 0.818 1.000 1.000 0.669
2 Supplier Quality (KP) 0.743 0.731 0.844 0.552
3 Employee involvement (KK) 0.703 1.000 1.000 0.495
4 Leadership Management (MK) 0.914 0.822 0.902 0.836
5 Customer orientation (OP) 0.830 0.674 0.805 0.688
6 Continuous improvement (PB) 0.860 1.000 1.000 0.740
7 Quality Management system (SMK) 0.802 1.000 1.000 0.363
R Square Business Performance (Y) = 99.6% (strong model) ; GoF Index = 0.690 (Substantial)
Table 6: Correlation Analysis (PLS-Bootsrapping’s result)







1 Innovation Strategy (X1) à TQM (X2)* 0.8180 0.8170 32.2970 0.000
2 Innovation Strategy à Business Performance (Y)** 0.4360 0.4400 7.1010 0.000
3 TQM (X2) à Business Performance (Y) 0.4890 0.4850 7.1370 0.000
*Analysis using standard indicator approach
**Analysis using Extended repeated indicator approach (two stage approach)
Two tailed test, level of significance : 95%
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5. CONCLUSION
This study examines the relationship between innovation
strategy, TQM and business performance. A proposed model
comprises four types of innovation strategy, seven TQM prac-
tices, and four perspectives to measure business performance.
To test the proposed model, data were collected from a sample
of Indonesian pharmaceutical companies that represents at least
fifty percent of the market share of the pharmaceutical industry
that produced generic drugs and participated in providing drugs
for the JKN program. The results of the analysis show that in-
novation strategies and TQM practices are interconnected and
both innovation strategy and TQM can improve a company’s
business performance in all dimensions. In particular, the re-
sults indicate management innovation has the biggest contribu-
tion to the company’s innovation strategy and leadership man-
agement has the biggest impact on TQM implementation.
Limitations of this study should be recognized to provide
researchers with future research opportunities. First, respon-
dents for this study are Indonesian pharmaceutical companies
that manufactured generic drugs and participated in providing
drugs for the JKN program. The firms fit the research purpose
because they are affected by JKN implementation. However,
other pharmaceutical firms, that did not manufacture generic
drugs might have been left out of this study, whereas they could
be more innovative. It would be promising to replicate this
research using data collected from firms that produced both
generic and branded products. Further, it may not be possible
to generalize our findings for firms that are not manufactured
generic products, since our data involves only generic manu-
facturers firms, the findings of this study may not be applicable
to non-generic manufacturer firms. Future studies could be con-
ducted to examine the relationship between innovation strategy
and TQM practices in both generic product manufacturer firms
and branded product manufacturer firms. Second, it would be
worthwhile to consider conducting case studies to get an in-
depth insight on how innovative and TQM-driven firms improve
their business performance and why management innovation is
contributed the most important in executing innovation strategy
and leadership management is the most important among TQM
practices.
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